Half Year, Uh

The FDA just approved Janssen's new version of antipsychotic paliperidone, Invega Hafyera, whose trade name (phonetically speaking?) reminds us of its claimed duration of action of six months. I would love to have witnessed the discussions over whether to use such a silly product name, hearing all the arguments for and against.

There's nothing funny about schizophrenia. For this drug to last half a year will increase its value to many, maybe even saving lives. Even those who suffer from the disorder have a sense of humor. I hope they all get a big chuckle out of this name.

Good on Janssen for having the courage to use this name.

Berry Edwards, MD